You are here: Industry Insights > COVID-19

News List

GSK partners with Innovax Biotech on Covid-19 vaccine pharmaceutical-technology
April 07, 2020
GlaxoSmithKline (GSK) has partnered with Xiamen Innovax Biotech to support the development of a recombinant protein-based vaccine candidate against Covid-19.
XBiotech and BioBridge to develop plasma-based Covid-19 therapy pharmaceutical-technology
April 07, 2020
Biopharmaceutical firm XBiotech has partnered with non-profit BioBridge Global to develop a Covid-19 therapy using natural antibodies from convalescent plasma of recovered patients.
Akers, Premas Progress Covid-19 Vax Development contractpharma
April 07, 2020
Akers Biosciences collaboration with Premas Biotech has successfully completed the milestone of obtaining clones of all three coronavirus antigens, Spike (S), Envelope (E), and Membrane (M) that they have selected for their vaccine candidate.
Izana Initiates Namilumab Study in Worsening COVID-19 contractpharma
April 07, 2020
Compassionate use study of monoclonal antibody therapy will be evaluated in rapidly worsening COVID-19 patients in Italy.
BioSig Acquires Anti-viral Agent to Treat COVID-19 contractpharma
April 07, 2020
Laboratory results demonstrate high level of activity against COVID-19 in cell culture.
LakePharma Offers COVID-19 Proteins to Biotechs contractpharma
April 07, 2020
Provides recombinant COVID-19 proteins to facilitate antibody and diagnostic development against COVID-19.
Zymewire Launches CovidCollaborators.org contractpharma
April 07, 2020
Zymewire, a SaaS company with over 300 clients across the drug development sector, has launched CovidCollaborators.org, an online directory of expert, pro-bono, and discounted clinical development.
BGI Unveils Inflatable Biosafety Lab for COVID-19 Testing contractpharma
April 07, 2020
COVID-19 has highlighted the need for countries to rapidly build-up screening and testing infrastructure.
COVID-19 Therapeutics: Summary of Recently Published Clinical Study using Hydroxychloroquine americanpharmaceuticalreview
April 06, 2020
Hydroxychloroquine sulphate (Plaquenil) an analog of chloroquine has an established track record for treating malaria and has demonstrated in vitro activity against the SARS-CoV and therefore being considered as possible treatment for COVID-19.
Influenza antiviral Avigan® (favipiravir) to enter Phase III trials in COVID-19 patients europeanpharmaceuticalreview
April 06, 2020
The developers of Avigan have increased production and announced a Phase III clinical trial testing its efficacy against COVID-19.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 437 438 Next page